FY18
Assets53.93
Net Worth20.69
Total Debt23.12
RevenueAnnualised basis42.37
EBITDAAnnualised basis8.02
PATAnnualised basis1.49
EBITDA Margin (%)18.93
At a glance
Updated 2026-09-06Par Drugs and Chemicals is an IPO with an issue size of ₹8.53 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹8.53 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets51.35₹ Cr · -8.4% vs prior year
Net Worth29.11₹ Cr · +51.6% vs prior year
FY17
Assets56.04
Net Worth19.20
Total Debt24.80
RevenueAnnualised basis48.76
EBITDAAnnualised basis8.50
PATAnnualised basis1.84
EBITDA Margin (%)17.43
31-Mar-19
Assets51.35
Net Worth29.11
Total Debt11.58
RevenueAnnualised basis46.32
EBITDAAnnualised basis8.28
PATAnnualised basis2.41
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Par Drugs and Chemicals IPO | — | 13.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Par Drugs and Chemicals without missing an update
Register for subscription, GMP, allotment and listing notifications.